Summary
- Current Price
- As of today, NVO price is $49.57, up +1.31% on
- Current Price All-Time High
- NVO price is currently -66.54% below its historical high of $148.15 set on
- Market Cap
- NVO current market cap is $220B, down -37.06% year-over-year
- PE Ratio
- NVO current PE ratio is 14.29
- Revenue
- NVO current annual revenue is $46.74B, up +10.97% year-over-year
- Next Earnings
- The next earnings release for NVO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Novo Nordisk A/S |
| Ticker | NYSE: NVO |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | Denmark |
| IPO | |
| Indexes | Not included |
| Website | novonordisk.com |
| Employees | 77,406 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $49.57 | |
| Price, 1D Change | +1.31% | |
| Market Cap | $220B | |
| TTM Dividend Yield | 3.48% | |
| PE Ratio | 14.29 | |
| Beta | 0.98 | |
| Revenue | $47B | |
| Revenue, 1Y Change | +10.97% | |
| EPS | $3.48 | |
| EPS, 1Y Change | +6.13% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.58 | |
| Next Ex-Dividend | $1.28 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $3.48 | |
| EPS Estimate | N/A | $21.12 |
| EPS Est. Change | N/A | +506.54% |
| Revenue | $46.74B | |
| Revenue Estimate | N/A | $292.37B |
| Revenue Est. Change | N/A | +525.59% |
| Current Price | $49.57 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $22.86 | $3.28 | -85.64% | |
| $23.17 | $3.48 | -84.97% | |
| $21.12 | N/A | +506.54% | |
| $22.31 | N/A | +540.60% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $287.76B | $42.12B | -85.36% | |
| $307.48B | $46.74B | -84.80% | |
| $292.37B | N/A | +525.59% | |
| $309.92B | N/A | +563.12% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -37.12% | |
| Price, 3Y | -30.67% | |
| Market Cap, 1Y | -37.06% | |
| Market Cap, 3Y | -31.61% | |
| Revenue, 1Y | +10.97% | |
| Revenue, 3Y | +86.95% | |
| EPS, 1Y | +6.13% | |
| EPS, 3Y | +101.77% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $49.57 | |
| SMA 200 | $58.24 | |
| SMA 200 vs Price | +17.49% | |
| SMA 50 | $53.30 | |
| SMA 50 vs Price | +7.53% | |
| Beta | 0.98 | |
| ATR | $2.49 | |
| 14-Day RSI | 41.74 | |
| 10-Day Volatility | 106.99% | |
| 1-Year Volatility | 53.20% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.58 | |
| Upcoming | $1.28 | |
| Dividend Yield | 3.48% | |
| Total Dividend | $1.73 | |
| Dividends Paid | $7.83B | |
| Payout Ratio | 50.53% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $46.74B | |
| EPS | $3.48 | |
| Gross Profit | $37.85B | |
| Gross Margin | 80.98% | |
| Operating Profit | $19.35B | |
| Operating Margin | 41.40% | |
| Net Income | $15.49B | |
| Net Margin | 33.14% | |
| EBITDA | $22.67B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.67 | |
| Current Ratio | 0.80 | |
| Quick Ratio | 0.57 | |
| - | ||
| F-Score | 5 | |
| Altman Z-Score | 4.11 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 14.29 | |
| PS Ratio | 4.71 | |
| PB Ratio | 9.52 | |
| EV/EBITDA | 10.46 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $23.13B | |
| Cash & Equivalents | $4.24B | |
| Total Assets | $85.37B | |
| Current Assets | $27.12B | |
| Total Liabilities | $54.85B | |
| Current Liabilities | $33.91B | |
| Total Debt | $20.59B | |
| Short Term Debt | $1.89B | |
| Accounts Payable | $3.11B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $31.25B | |
| Operating Expenses | $18.50B | |
| Cost Of Goods Sold | $8.89B | |
| SG&A | $0.00 | |
| D&A | $3.32B | |
| Interest Expense | $0.00 | |
| Income Tax | $4.25B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $18.01B | |
| CFI | -$11.97B | |
| CFF | -$4.30B | |
| Capex | $13.63B | |
| Free Cash Flow | $4.38B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| CICC | ||
| Argus Research | → | |
| Goldman Sachs | → | |
| BMO Capital | → | |
| HSBC | → | |
| BMO Capital | → | |
| HSBC | → | |
| Morgan Stanley | → | |
| Berenberg | → | |
| TD Cowen | → |
Analyst sentiment
Institutional ownership
Screeners with NVO
FAQ
What is the ticker symbol for Novo Nordisk A/S?
The ticker symbol for Novo Nordisk A/S is NYSE:NVO
Does Novo Nordisk A/S pay dividends?
Yes, Novo Nordisk A/S pays dividends. The last payment was $0.58, with an ex-dividend date on August 18, 2025
What sector is Novo Nordisk A/S in?
Novo Nordisk A/S is in the Healthcare sector
What industry is Novo Nordisk A/S in?
Novo Nordisk A/S is in the General Drug Manufacturers industry
What country is Novo Nordisk A/S based in?
Novo Nordisk A/S is headquartered in Denmark
When did Novo Nordisk A/S go public?
Novo Nordisk A/S initial public offering (IPO) was on April 30, 1981
Is Novo Nordisk A/S in the S&P 500?
No, Novo Nordisk A/S is not included in the S&P 500 index
Is Novo Nordisk A/S in the NASDAQ 100?
No, Novo Nordisk A/S is not included in the NASDAQ 100 index
Is Novo Nordisk A/S in the Dow Jones?
No, Novo Nordisk A/S is not included in the Dow Jones index
When was Novo Nordisk A/S last earnings report?
Novo Nordisk A/S's most recent earnings report was on February 3, 2026
When does Novo Nordisk A/S report earnings?
The next expected earnings date for Novo Nordisk A/S is May 6, 2026
Data Sources & References
- NVO Official Website www.novonordisk.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm
- NVO Profile on Yahoo Finance finance.yahoo.com/quote/NVO
- NVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvo
